1. Clinical Overview
A fixed-dose combination topical medication containing a moderate-potency corticosteroid (Betamethasone) and a second-generation fluoroquinolone antibiotic (Ofloxacin). It is primarily used for the treatment of inflammatory dermatoses with secondary or suspected bacterial infections, particularly those caused by susceptible aerobic gram-positive and gram-negative organisms. The combination provides anti-inflammatory, anti-pruritic, vasoconstrictive, and antibacterial actions.
| Onset | Duration | Bioavailability |
|---|---|---|
| Anti-inflammatory effects begin within 1-3 hours; antibacterial effects begin upon contact with susceptible organisms. | Topical corticosteroid effects can last 12-24 hours per application; antibacterial effect is concentration-dependent and persists as long as therapeutic levels are maintained at the site. | Topical bioavailability is low but variable (<5% for Betamethasone, <0.5% for Ofloxacin through intact skin). Significantly higher through broken skin, inflamed skin, or under occlusion. |
2. Mechanism of Action
Betamethasone exerts potent anti-inflammatory, immunosuppressive, and vasoconstrictive effects by inducing phospholipase A2 inhibitory proteins (lipocortins), which inhibit the release of inflammatory mediators like prostaglandins and leukotrienes. It also inhibits the recruitment and activity of inflammatory cells. Ofloxacin is a bactericidal antibiotic that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, leading to rapid bacterial cell death.
3. Indications & Uses
- Infected eczema (bacterial)
- Infected psoriasis
- Infected contact dermatitis
- Infected seborrheic dermatitis
- Secondarily infected traumatic skin lesions
- Bacterial superficial folliculitis (where inflammation is significant)
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area 1 to 2 times daily. Duration should be limited, typically 1-2 weeks. Re-evaluate if no improvement within 3-5 days.
Administration: Wash and dry the affected area gently. Apply a thin layer and rub in lightly. Do not bandage or cover with occlusive dressings unless specifically directed by a physician. Wash hands before and after application, unless hands are the treatment area. Avoid contact with eyes, nose, mouth, and mucous membranes.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation
- Itching (pruritus) at application site
- Dryness of skin
- Erythema
- Skin irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of local and systemic adverse effects (atrophy, HPA suppression). | Major |
| Systemic Corticosteroids (e.g., Prednisolone) | Increased risk of systemic corticosteroid side effects and HPA axis suppression. | Major |
| Non-steroidal Anti-inflammatory Drugs (NSAIDs) topical/systemic | May increase risk of CNS stimulation, seizures (fluoroquinolone effect). | Moderate |
| Oral Anticoagulants (e.g., Warfarin) | Ofloxacin may potentiate anticoagulant effect; monitor INR (relevant if significant systemic absorption). | Moderate |
| Theophylline | Ofloxacin may increase theophylline serum levels, risk of toxicity. | Moderate |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole) | May increase systemic levels of betamethasone if absorbed. | Moderate |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO wash hands before and after application.
- DO apply a thin layer only.
- DO report any lack of improvement or worsening after 3-5 days.
- DON'T use on larger areas or for longer than prescribed.
- DON'T cover the area with tight bandages or plastic wraps unless told by your doctor.
- DON'T use on the face, groin, or armpits unless directed.
- DON'T let the medication get into your eyes, nose, or mouth.
- DON'T use if you are allergic to any ingredient or other quinolone antibiotics.
8. Toxicology & Storage
Overdose: Topical overdose can lead to: 1) Local: Severe skin atrophy, striae, ulceration, hypersensitivity. 2) Systemic (from prolonged, extensive use): Symptoms of hypercorticism (moon face, central obesity, hypertension), HPA axis suppression (weakness, nausea, hypotension), and potential fluoroquinolone toxicity (CNS effects, tendon issues).
Storage: Store at room temperature (15-25°C). Protect from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.